Clinical trial
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic…
NCT00282906 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00282906 |
|---|---|
| Title | FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer |
| Official title | [F-18]-Fluorodeoxyglucose (FDG) Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer |
| Lead sponsor | University of Southern California, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Device |
| Interventions | hybrid PET-CT imaging system |
| Enrollment | 257 |
| Start date | Oct 3, 2005 |
| Primary completion | Dec 19, 2013 |
| Completion | Aug 19, 2014 |
| First posted | Jan 27, 2006 |
| Last update posted | Apr 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: